RedHill Biopharma (RDHL) Cash from Operations (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Cash from Operations of 2421000.0 for Q4 2022, up 83.71% year-over-year from 1317860.53 in Q4 2021, and up 59.84% quarter-over-quarter from 6028000.0 in Q3 2022.
RedHill Biopharma (RDHL) Cash from Operations (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Cash from Operations for 11 consecutive years, with 2421000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Cash from Operations rose 83.71% year-over-year to 2421000.0; the TTM figure through Dec 2022 stood at 29185000.0 (up 55.13% YoY), while the FY2025 annual figure was 9651000.0, down 3.01% from the prior year.
- Cash from Operations improved to 2421000.0 in Q4 2022 per RDHL's latest filing, from 6028000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2421000.0 in Q4 2022 and bottomed at 19025000.0 in Q3 2021.
- Historically, Cash from Operations has averaged 10848650.0 across 5 years, with a median of 9974500.0 in 2018.
- Annual changes were most pronounced in 2021 — Cash from Operations plunged 107.45% — and 2022, when it surged 83.71%.
- RedHill Biopharma's Cash from Operations stood at 8194000.0 in 2018, then plunged by 69.26% to 13869000.0 in 2019, then rose by 8.39% to 12705000.0 in 2020, then slipped by 16.95% to 14859000.0 in 2021, then soared by 83.71% to 2421000.0 in 2022.
- Business Quant data shows RDHL's Cash from Operations at 2421000.0 in Q4 2022, 6028000.0 in Q3 2022, and 16581000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2.42 Mn |
| Dec 31, 2022 | -2.42 Mn |
| Sep 30, 2022 | -6.03 Mn |
| Sep 30, 2022 | -6.03 Mn |
| Jun 30, 2022 | -16.58 Mn |
| Jun 30, 2022 | -16.58 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Mar 31, 2022 | -4.16 Mn |
| Dec 31, 2021 | -14.86 Mn |
| Dec 31, 2021 | -14.86 Mn |
| Sep 30, 2021 | -19.03 Mn |
| Sep 30, 2021 | -19.03 Mn |
| Jun 30, 2021 | -18.90 Mn |
| Jun 30, 2021 | -18.90 Mn |
| Mar 31, 2021 | -12.27 Mn |
| Mar 31, 2021 | -12.27 Mn |
| Dec 31, 2020 | -12.71 Mn |
| Dec 31, 2020 | -12.71 Mn |
| Sep 30, 2020 | -9.17 Mn |
| Sep 30, 2020 | -9.17 Mn |